Estrogen Regulation of the Expression of Pain Factor NGF in Rat Chondrocytes.

Xiushuai Shang,Liaoran Zhang,Rilong Jin,Hu Yang,Hairong Tao
DOI: https://doi.org/10.2147/jpr.s297442
IF: 2.8319
2021-01-01
Journal of Pain Research
Abstract:Objective: Pain is the main symptom of osteoarthritis (OA). Nerve growth factor (NGF) plays a crucial role in the generation of OA pain. And estrogen-alone used resulted in a sustained joint pain reduction in postmenopausal women. So we aim to find whether estrogen alters chondrocytes' NGF level, affecting OA pain. Methods: Primary chondrocytes and cartilage explants isolated from Sprague Dawley rat knees were cultured with physiological concentrations of estrogen (17 beta-Estradiol >= 98%, E2), Estrogen Receptor alpha (ER alpha) inhibitor and stimulants. Then, chondrocytes NGF mRNA expression and protein release were analyzed by a quantitative real-time polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA) respectively. Additionally, cultures were pre-incubated with MEK-ERK inhibitor to identify the signaling pathway that estrogen alters NGF mRNA and protein levels. Results: We found that chondrocytes NGF expression and release were decreased by E2. E2 also reduced chondrocytes IL-1 beta-stimulated or TGF-beta 1-stimulated NGF expression. Phosphorylated extracellular signal-regulated kinasep1/2 (p-ERK1/2) signals were detected stronger than the control group by Western Blotting (WB). When we cultured chondrocytes with PD98059 (MEK-ERK inhibitor, PD), NGF mRNA expression was added to 1.41Ct (2.07 +/- 0.1 fold). Conclusion: We showed that E2 reduces chondrocytes NGF expression significantly, even after stimulation by TGF-beta 1 or IL-1 beta. MEK-ERK signaling is involved in this process.
What problem does this paper attempt to address?